NME1 (Nm23‐H1), a cellular target of the Epstein–Barr virus nuclear antigen EBNA3C, interacts with necdin and antagonizes necdin‐mediated growth suppression and anti‐angiogenic function in cancer cells (Kaul et al., 2009). This evidence concerns the gene NME1 and cancer.